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Edited by Michael R. BubbAbstract Slingshot-1L (SSH1L) is a phosphatase that speciﬁ-
cally dephosphorylates and activates coﬁlin, an actin-severing
and -depolymerizing protein. SSH1L binds to and is activated
by F-actin in vitro, and co-localizes with F-actin in cultured cells.
We examined the F-actin-binding activity, F-actin-mediated
phosphatase activation, and subcellular distribution of various
mutants of SSH1L. We identiﬁed three sites involved in F-actin
binding of SSH1L: Trp-458 close to the C-terminus of the phos-
phatase domain, an LHK motif in the N-terminal region, and an
LKR motif in the C-terminal region. These sites play unique
roles in the control of subcellular localization and F-actin-medi-
ated activation of SSH1L.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Actin ﬁlament dynamics play an essential role in various cell
activities, including migration, morphological change and
cytokinesis. Coﬁlin is an actin-binding protein that severs actin
ﬁlaments and stimulates depolymerization, thereby playing a
key role in actin ﬁlament dynamics and reorganization [1,2].
Coﬁlin is inactivated through phosphorylation of Ser-3 by
LIM-kinases or related TES-kinases [3–5], and the inactive
Ser-3-phosphorylated coﬁlin (P-coﬁlin) is reactivated through
dephosphorylation by Slingshot (SSH) family protein phos-
phatases, composed of SSH1L, -2L and -3L in mammals [6,7].
We previously showed that a long form of Slingshot-1
(SSH1L) binds to F-actin in cell-free assays and co-localizes
with F-actin in cultured cells [6,7]. We also found that the coﬁ-
lin-phosphatase activity of SSH1L is markedly enhanced by its
association with F-actin [8]. After cell stimulation with growth
factors or chemokines, SSH1L is translocated into F-actin-rich
lamellipodia where it is activated by F-actin, and consequently
dephosphorylates and activates coﬁlin locally in the lamellipo-Abbreviations: FL, full-length; P-coﬁlin, Ser-3-phosphorylated coﬁlin;
SSH, Slingshot; SSH1L, a long form of Slingshot-1; WT, wild-type
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has been shown to impair directional cell migration [10]. These
results suggest that F-actin-binding and F-actin-mediated acti-
vation of SSH1L are crucial to directional cell migration
through local stimulation of coﬁlin activity and changes in ac-
tin ﬁlament dynamics in the lamellipodium [10].
In the present study, we examined the F-actin-binding activ-
ity, F-actin-mediated phosphatase activation, and subcellular
localization of various deletion and amino acid substitu-
tion mutants of SSH1L. Our results suggest that there are at
least three F-actin-binding sites in SSH1L and that these
sites are diﬀerentially involved in the subcellular localization
and F-actin-mediated activation of SSH1L.2. Materials and methods
2.1. Plasmid construction
Expression plasmids encoding C-terminally (Myc+His)-tagged (con-
sisting of a Myc epitope peptide and six His residues) human SSH1L
were constructed using the pcDNA3.1/Myc-His(+) vector (Invitro-
gen), as described [6]. The plasmids encoding deletion mutants of hu-
man SSH1L were generated by PCR ampliﬁcation and subcloning
into the pcDNA3.1/Myc-His(+) vector. The plasmids for substitu-
tion mutants were constructed using a site-directed mutagenesis kit
(Stratagene).
2.2. F-actin co-sedimentation assay
The F-actin co-sedimentation assay was performed as described pre-
viously [6,7]. Rabbit skeletal muscle actin (Sigma) was polymerized
into F-actin by incubating at 20 C for 1 h in F-buﬀer (50 mM Tris–
HCl, pH 6.8, 100 mM NaCl, 0.2 mM ATP, 2 mM MgCl2, 0.2 mM
CaCl2, and 1 mM dithiothreitol). (Myc+His)-tagged SSH1L mutants,
expressed in 293T cells, were puriﬁed on Ni-NTA-agarose, eluted with
15 ll of 0.5 M imidazole/50 mM HEPES (pH 7.4), and diluted with
55 ll of F-buﬀer. The molar concentration of each SSH1L mutant
was adjusted, based on the calculated molecular weight and the densi-
tometric intensity of the immunoblot, compared with the amounts of
standard SSH1L puriﬁed from baculovirus expression system. Co-sed-
imentation assay was done by adding 30 ll of solution containing
about 0.36 lM SSH1L mutants and 0.1 mg/ml BSA to 30 ll of F-buf-
fer containing 20 lM polymerized actin. After incubation for 1 h at
20 C, the reaction mixture was centrifuged at 100000 · g for 30 min,
and equal portions of the supernatant and pellet were separated by
SDS–PAGE, and analyzed by immunoblotting using an anti-Myc
monoclonal antibody (9E10; Roche Applied Science) and Amido
Black staining.
2.3. Coﬁlin-phosphatase assay
SSH1L-(Myc+His) and its mutants expressed in 293T cells were
immunoprecipitated with anti-Myc antibody and incubated for 1 h
at 30 C with 100 ng coﬁlin-(His)6 in the presence or absence of 5 lgblished by Elsevier B.V. All rights reserved.
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SDS–PAGE, and P-coﬁlin was analyzed by staining with the Pro-Q
Diamond phosphoprotein gel stain kit (Invitrogen).
2.4. Cell culture and staining
HeLa and 293T cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal calf serum. HeLa and 293T cells
were transfected, using Lipofectamine (Invitrogen) and FuGene6
(Roche Applied Science), respectively. For cell staining, HeLa cells
were ﬁxed and co-stained with anti-Myc antibody (9E10) and rhoda-
mine-phalloidin (Molecular Probes), as described [7].3. Results
3.1. Identiﬁcation of F-actin-binding sites of SSH1L
SSH1L has the domain structure, composed of the N-ter-
minal A, B, P (phosphatase) domains, conserved betweenFig. 1. Identiﬁcation of F-actin-binding regions of SSH1L. (A) Schematic dia
of SSH family proteins are denoted as A, B, P (phosphatase) and S (serine-ri
asterisk indicates the site where Cys-393 was replaced by Ser. The relative am
Fig. 1C) are noted at the right of the diagram. n.d., not determined. (B) Ex
mutants expressed in 293T cells were separated on 9% and 15% SDS–PAGE
expressing P(WT) or P(CS), equal portions of soluble (S) and insoluble (I) fra
(C) F-actin-binding assays of SSH1L mutants. SSH1L-(Myc+His) and its m
concentrations of SSH1L mutants were incubated with (+) or without () F-a
(S) fractions were analyzed by immunoblotting with anti-Myc antibody. Acan SSH family, and the S (serine-rich) domain near the C-ter-
minus, conserved between SSH1L and 2L (Fig. 1A). To
determine the F-actin-binding site(s) of SSH1L, we
constructed expression plasmids coding for a set of deletion
mutants of SSH1L (Fig. 1A). The C-terminally (Myc+His)-
tagged SSH1L and its mutants were expressed in 293T cells.
Immunoblot analyses of cell lysates using an anti-Myc anti-
body conﬁrmed the expression of SSH1L mutant proteins
of the predicted molecular sizes (Fig. 1B). Since the wild-type
phosphatase domain fragment [P(WT)] was insoluble, but its
phosphatase-dead form [P(CS)] (catalytic Cys-393 replaced by
Ser) was soluble (Fig. 1B), we used P(CS) for the F-actin-
binding assays. The almost equimolar concentrations of
SSH1L-(Myc+His) mutants puriﬁed from cell lysates were
subjected to an in vitro F-actin co-sedimentation assay
(Fig. 1C). The assays revealed that the full-length (FL)
SSH1L almost completely co-sedimented with F-actin. Ingrams of SSH1L and its deletion mutants. The highly conserved regions
ch) domains [7]. Numbers on the bars indicate amino acid residues. An
ounts of SSH1L mutants co-sedimenting with F-actin (estimated from
pression of SSH1L and its mutants. (Myc+His)-tagged SSH1L and its
and analyzed by immunoblotting with anti-Myc antibody. For cells
ctions of the cell lysates were analyzed by immunoblotting (right panel).
utants expressed in 293T cells were puriﬁed and the almost equimolar
ctin. After centrifugation, equal amounts of pellet (P) and supernatant
tin was detected by Amido black staining.
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N960, N896 and N461, was weaker and only about half of
these deletion mutant proteins co-sedimented with F-actin.
These data suggest that the C-terminal region (amino acids
961–1049) is involved in the F-actin-binding activity of
SSH1L. The N-terminal deletion mutant BPC almost com-
pletely co-sedimented with F-actin, but only about half of
PC and C509 mutants did, which indicates the involvement
of the B domain (amino acids 119–283) in F-actin binding
of SSH1L. The phosphatase domain fragment [P(CS)] did
not bind to F-actin. Interestingly, the F-actin-binding activity
of NP was signiﬁcantly lower than that of N461, which sug-
gests that the short sequence of amino acids 457–461 is in-
volved in F-actin binding of SSH1L. Thus, the B domain
(amino acids 119–283), the short sequence near the C-termi-
nus of the phosphatase domain (amino acids 457–461), and
the C-terminal region (amino acid residues 961–1049) each
appear to be involved in F-actin-binding activity of SSH1L.
To further deﬁne the F-actin-binding sites of SSH1L, we
constructed various site-directed mutants of SSH1L fragments.
To determine the residue(s) essential for F-actin binding of
SSH1L in the region of amino acids 456–461, we constructed
a set of substitution mutants of N461 and examined their F-ac-
tin-binding activity (Fig. 2A). Co-sedimentation assays re-
vealed that only faint amounts of the W458A (Trp-458
replaced by Ala) and 3A (Leu-457, Trp-458 and Arg-459Fig. 2. Identiﬁcation of amino acid residues of SSH1L involved in F-actin bin
tagged N461 point mutants were expressed in 293T cells and analyzed as in Fi
in SSH1L with the LKHAET-like actin-binding motifs in various actin-bind
C915. (Myc+His)-tagged NP and C915 point mutants were expressed in 293replaced by Ala) mutants of N461 co-sedimented with F-actin,
whereas other substitution mutants bound to F-actin at levels
similar to that of N461(WT). This suggests that the Trp-458
residue is critical for F-actin binding of SSH1L.
Previous studies have proposed that motifs homologous to
LKHAET in actobindin (Fig. 2B) form a short actin-binding
site [11–14]. The LKHAET-like motif is found in many ac-
tin-binding proteins, including villin, thymosin-b4, and verpr-
olin [11–14]. On the basis of similarity to this motif, we
assumed that LHKACE (amino acids 185–190) in the B do-
main and LKRSHS (amino acids 973–978) in the S domain
of SSH1L might be involved in F-actin binding. Co-sedimenta-
tion assays revealed that the F-actin-binding activities of
NP(3A) (Leu-185, His-186, and Lys-187 replaced by Ala)
and C915(3A) (Leu-973, Lys-974, and Arg-975 replaced by
Ala) were signiﬁcantly decreased, compared to the parental
NP and C915 fragments (Fig. 2C). In contrast, the C915(5A)
mutant, in which ﬁve basic amino acids (Arg-1023, Lys-1030,
Lys-1034, Lys-1041, and Lys-1048) near the extremely C-ter-
minus were replaced by Ala, bound to F-actin at a level similar
to that of C915(WT), indicating that these basic residues are
not required for F-actin binding of C915 (Fig. 2C). Taken to-
gether these results suggest that there are at least three sites in-
volved in F-actin binding of SSH1L: Trp-458 in the C-terminal
region ﬂanking the P domain, an LHK motif in the B-domain,
and an LKR motif in the S domain.ding. (A) F-actin-binding assays of point mutants of N461. (Myc+His)-
g. 1C. (B) Alignment of the sequences of the putative actin-binding sites
ing proteins. (C) F-actin binding assays of point mutants of NP and
T cells and analyzed as in Fig. 1C.
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We previously showed that SSH1L phosphatase activity is
highly stimulated by F-actin [8]. Our data also demonstrated
that the phosphatase activity of N960, N698 and N461 were
activated by F-actin, but the activity of NP and
N461(W458A) was not, indicating that Trp-458 is crucial for
F-actin-mediated activation of SSH1L [10]. In this study, we
examined whether or not the N-terminally truncated BPC mu-
tant is activated by F-actin. (Myc+His)-tagged SSH1L mu-
tants were subjected to an in vitro coﬁlin-phosphatase assay
in the presence or absence of F-actin, using P-coﬁlin as a sub-
strate (Fig. 3). As previously reported [8,10], SSH1L(FL) was
activated by F-actin, but NP or phosphatase-dead C393S mu-
tant was not. Unexpectedly, BPC was not activated by F-actin,
although it retained almost complete F-actin-binding activity.
This suggests that the A domain is involved in the process of
F-actin-mediated activation.
3.3. Subcellular localization of SSH1L mutants
We next examined the subcellular distribution of SSH1L
mutants. (Myc+His)-tagged SSH1L and its mutants were ex-
pressed in HeLa cells and the cells were co-stained with an
anti-Myc antibody to detect SSH1L mutants and rhodamine-
phalloidin to detect F-actin (Fig. 4). As reported [6,7],
SSH1L(FL) co-localized well with F-actin and accumulated
on the cortical actin bundles at the cell periphery and on stress
ﬁbers. In contrast, the C-terminal truncation mutants, N896
(data not shown), and N960 and N461 (Fig. 4), only partially
co-localized with actin ﬁlaments at the cell periphery. In con-
trast to N461, N461(W458A) was distributed diﬀusely in the
cytoplasm. This correlates well with the ﬁndings of the
in vitro F-actin-binding assay (Fig. 2A) and further suggestsFig. 3. F-actin-mediated activation of SSH1L and its mutants.
(Myc+His)-tagged SSH1L mutants were precipitated with anti-Myc
antibody and subjected to an in vitro phosphatase assay, using (His)6-
coﬁlin as a substrate, in the presence or absence of F-actin. Coﬁlin-
phosphatase activity was assessed by Pro-Q and Coomassie brilliant
blue (CBB) staining of P-coﬁlin and coﬁlin, respectively. SSH1L
mutants and actin in the reaction mixtures were analyzed with anti-
Myc and CBB staining.that Trp-458 plays a critical role in F-actin-binding. NP par-
tially co-localized with F-actin near the plasma membrane at
the cell periphery, but NP(3A) diﬀusely distributed in the cyto-
plasm, which indicates that the LHK motif in the B-domain
plays a role in SSH1L co-localization with F-actin near the
plasma membrane. BPC co-localized well with F-actin and
accumulated both on the cortical actin bundles and stress ﬁ-
bers, but PC and C509 only partially co-localized with F-actin
at the cell periphery, which further implicates the B domain in
F-actin association. In contrast to C509, C915 co-localized
well with stress ﬁbers, which suggests that the region of amino
acids 509–914 may have some inhibitory eﬀect on the localiza-
tion of C915 on stress ﬁbers. P(CS) was diﬀusely distributed in
the cytoplasm, whereas P(WT) was detected as speckles in the
cytoplasm. Since P(WT) was not solubilized by cell lysis
(Fig. 1B), the punctate distribution is likely to represent insol-
uble aggregates within the cell.4. Discussion
Our data demonstrate that SSH1L has at least three
F-actin-binding sites in diﬀerent domains of the protein. Char-
acterization of various SSH1L mutants indicates that these ac-
tin-binding sites play diﬀerent roles in regulating the
subcellular localization and F-actin-mediated activation of
SSH1L. The C-terminal deletion mutants (N960, N896,
N698 and N461) had reduced actin-binding activity and only
partially co-localized with F-actin, but were fully activated
by F-actin [10 and in this study]. These data indicate that
the LKR actin-binding motif in the C-terminal region is in-
volved in the localization of SSH1L to actin ﬁlaments in cells
but does not contribute to the process of F-actin-induced
phosphatase activation. In contrast, Trp-458 near the C-terminus
of the phosphatase domain is indispensable for F-actin-mediated
activation of SSH1L [10]. BecauseNP, but not NP(3A), has weak
F-actin-binding activity and co-localized with F-actin near the
plasma membrane, the LHK motif in the B domain is likely in-
volved in the localization of SSH1L to F-actin near the plasma
membrane. Interestingly, BPCwas not activated by F-actin, even
though it displayed almost complete F-actin-binding activity.
Since BPC retained the basal coﬁlin-phosphatase activity (activity
in the absence of F-actin), the A domain is required for F-actin-
mediated activation, but not for basal activity. The A domain
may be involved in F-actin-mediated activation through
co-operative interactions with Trp-458.
We previously showed that 14-3-3 proteins bind to SSH1L,
and this binding required the phosphorylation of Ser-937
and Ser-978 of SSH1L [8]. In unstimulated cells, 14-3-3 pro-
teins negatively regulate SSH1L activity by sequestering it in
the cytoplasm and preventing F-actin-mediated activation
[8]. Since the LKR actin-binding motif in the S domain is very
close to one of the 14-3-3 binding sites (Ser-978), it is possible
that 14-3-3 proteins sterically hinder SSH1L binding to
F-actin.
Overexpression of the phosphatase-dead (CS) form of full-
length SSH1L frequently evoked robust assembly of actin ﬁla-
ments within cells [6,7]. Expression of WT SSH1L can induce
aberrantly thick actin bundles, as well, although this eﬀect was
noted infrequently [7,15]. These data suggest that the full-
length SSH1L has F-actin-bundling activity, irrespective of
Fig. 4. Subcellular localization of SSH1L and its mutants. (Myc+His)-tagged SSH1L mutants were expressed in HeLa cells. Cells were co-stained
with anti-Myc for SSH1L mutants (right panels) and rhodamine-phalloidin for F-actin (left panels). Arrowheads in panels for N960, N461, NP, PC
and C509 indicate the positions where SSH1L mutants co-localize with F-actin. Scale bar, 10 lm.
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tants, such as N461, NP, and C508, did not induce such phe-
notypes, multiple F-actin-binding sites in SSH1L may be
related to the F-actin-bundling activity of SSH1L.
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